PPARβ/δ preconditioning increased the cardioprotective effects of MSC in IR injury

Archive ouverte

Contreras-Lopez, Rafael | Sarre, Charlotte | Nerpermpisooth, Nitirut | Vincent, Anne | Nargeot, Joel | Piot, Christophe | Jorgensen, Christian | Djouad, Farida | Barrère-Lemaire, Stéphanie

Edité par CCSD -

International audience. Mesenchymal Stromal/Stem Cells (MSC) have been widely used for their therapeutic properties in acute myocardial infarction (AMI) due to their pleiotropic anti-inflammatory, anti-apoptotic, anti-fibrotic and pro-angiogenic properties. Despite promising results in animal studies and their safety/efficacy in phase I/II trials, inconsistencies have been reported in phase III. We have recently shown in a mouse model of ischemia-reperfusion (IR) that the cardioprotective effect of MSC administered during reperfusion was dependent on the presence of PPARβ/δ receptors. However, the role of the modulation of PPARβ/δ on MSC anti-apoptotic and cardioprotective properties has never been investigated. Objectives: this study aims investigating the role of PPARβ/δ activation on MSC therapeutic properties in an ex vivo model of AMI and their anti-apoptotic functions on cardiac cells.Method: isolated mouse hearts were subjected to 30 minutes of global ischemia and 60 minutes of reperfusion (IR). Murine MSC (naïve MSC), MSCago (pretreated with GW0742 1 µM agonist) MSCantago (pretreated with GSK0660 1µM) were administered in the perfusion system during the reperfusion period. Specific DNA fragmentation was quantified in MSC or MSCago challenged with 350 µM H2O2 during 4 hours and in H9c2 rat cardiomyoblasts and EAhy926 human endothelial cells challenged with H2O2 and co-cultured with naïve or primed MSC.Results: MSCago injection during reperfusion decreased infarct size by a larger extent than MSC, an effect lost with MSCantago. Accordingly, an increased number of cells of MSCago was detected in the left ventricular wall after 1 hour of reperfusion. In vitro, we observed for MSCago an increased resistance against oxidative resistance and a more potent anti-apoptotic effect on both cardiomyocytes and endothelial cells in vitro than naive MSC.Conclusion: MSC preconditioning via PPARβ/δ enhanced their cardioprotective effect against IR injury ex vivo by both increasing their resistance to oxidative stress and their anti-apoptotic effects on myocytes and endothelial cells. These results could be of major interest to improve MSC efficacy for the cardioprotection of the myocardium in AMI patients.

Consulter en ligne

Suggestions

Du même auteur

PPARβ/δ Is Required for Mesenchymal Stem Cell Cardioprotective Effects Independently of Their Anti-inflammatory Properties in Myocardial Ischemia-Reperfusion Injury

Archive ouverte | Nernpermpisooth, Nitirut | CCSD

International audience. Myocardial infarction ranks first for the mortality worldwide. Because the adult heart is unable to regenerate, fibrosis develops to compensate for the loss of contractile tissue after infarc...

PPARβ/δ priming enhances the anti-apoptotic and therapeutic properties of mesenchymal stromal cells in myocardial ischemia–reperfusion injury

Archive ouverte | Sarre, Charlotte | CCSD

Une correction portant sur les affiliations a été ajoutée en annexe, DOI 10.1186/s13287-022-03086-6.. International audience. Background: Mesenchymal Stromal Cells (MSC) have been widely used for their therapeutic p...

PPARβ/δ preconditioning increased the cardioprotective effects of human MSC in IR injury

Archive ouverte | Contreras, Rafael | CCSD

International audience

Chargement des enrichissements...